ARCT vs RF
Arcturus Therapeutics Holdings Inc (ARCT) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
RF does not have a complete income-statement cache yet.
ARCT currently screens at market cap $369.4M. RF currently screens at market cap $0.
Not investment advice. Open the ARCT and RF stock pages for the full models.
Not investment advice.